Copyright
©The Author(s) 2022.
World J Gastroenterol. May 21, 2022; 28(19): 2123-2136
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2123
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2123
Table 1 Characteristics of non-severe acute pancreatitis and severe acute pancreatitis patients in derivation and validation cohort
Characteristic | Derivation cohort | P value | Validation cohort | P value | ||
non-SAP (n = 327) | SAP (n = 80) | non-SAP (n = 131) | SAP (n = 59) | |||
Age (yr) | 49.0 (36.0; 63.5) | 46.0 (34.8; 62.2) | 0.424 | 40.0 (32.0; 58.5) | 44.0 (38.0; 53.0) | 0.371 |
Female (%) | 131 (40.1) | 27 (33.8) | 0.363 | 63 (48.1) | 14 (23.7) | 0.003 |
Weekend admission (%) | 65 (19.9) | 26 (32.5) | 0.023 | 37 (28.2) | 13 (22.0) | 0.471 |
Etiology (%) | 0.021 | 0.003 | ||||
Biliary | 113 (34.6) | 31 (38.8) | 54 (41.2) | 11 (18.6) | ||
Hypertriglyceridemia | 113 (34.6) | 36 (45.0) | 44 (33.6) | 21 (35.6) | ||
Alcoholic | 27 (8.26) | 7 (8.75) | 5 (3.82) | 8 (13.6) | ||
Others | 74 (22.6) | 6 (7.50) | 28 (21.4) | 19 (32.2) | ||
Peritoneal irritation (%) | 74 (22.6) | 31 (38.8) | 0.005 | 27 (20.6) | 32 (54.2) | < 0.001 |
GCS < 15 (%) | 2 (0.61) | 5 (6.25) | 0.004 | 3 (2.29) | 7 (11.9) | 0.011 |
Tem (℃) | 36.6 (36.4; 37.0) | 37.2 (36.5; 38.2) | < 0.001 | 37.0 (36.8; 37.4) | 38.0 (37.5; 38.4) | < 0.001 |
SBP (KPa) | 17.2 (15.9; 18.7) | 16.4 (14.9; 18.8) | 0.119 | 16.3 (15.2; 18.4) | 16.8 (14.7; 19.5) | 0.949 |
HR (bpm) | 82.0 (76.0; 94.5) | 118 (99.5; 132) | < 0.001 | 89.0 (79.0; 102) | 110 (100; 130) | < 0.001 |
RR (bpm) | 20.0 (18.0; 20.0) | 22.0 (20.0; 28.2) | < 0.001 | 20.0 (18.0; 21.0) | 23.0 (20.5; 29.5) | < 0.001 |
WBC (× 109/L) | 11.6 (8.74; 15.2) | 14.2 (10.2; 18.7) | 0.001 | 12.4 (8.70; 15.6) | 16.4 (12.2; 21.1) | < 0.001 |
HCT (%) | 40.8 (37.5; 44.8) | 43.6 (36.9; 48.4) | 0.022 | 41.3 (37.8; 45.0) | 42.9 (36.5; 49.0) | 0.218 |
PLT (×109/L) | 221 (178; 276) | 192 (156; 274) | 0.03 | 232 (196; 278) | 202 (166; 264) | 0.025 |
K (mmol/L) | 3.90 (3.60; 4.25) | 3.90 (3.50; 4.30) | 0.817 | 3.90 (3.50; 4.10) | 4.00 (3.50; 4.55) | 0.074 |
Na (mmol/L) | 137 (134; 140) | 137 (132; 140) | 0.909 | 137 (133; 140) | 137 (133; 140) | 0.664 |
Ca (mmol/L) | 2.26 (2.13; 2.34) | 1.96 (1.74; 2.16) | < 0.001 | 2.22 (2.08; 2.32) | 1.93 (1.77; 2.10) | < 0.001 |
Cr (μmol/L) | 67.0 (55.0; 80.0) | 90.0 (70.8; 142) | < 0.001 | 61.0 (52.0; 77.0) | 90.0 (62.5; 227) | < 0.001 |
BUN (mmol/L) | 5.00 (3.88; 6.34) | 7.06 (5.26; 10.4) | < 0.001 | 4.66 (3.32; 5.84) | 6.67 (4.91; 14.2) | < 0.001 |
Glu (mmol/L) | 8.00 (6.50; 12.9) | 11.0 (7.45; 16.3) | < 0.001 | 8.70 (6.80; 11.8) | 11.3 (8.05; 17.2) | 0.004 |
Local complication (%) | 104 (31.8) | 73 (91.2) | < 0.001 | 66 (50.4) | 55 (93.2) | < 0.001 |
ICU admission (%) | 12 (3.67) | 37 (46.2) | < 0.001 | 12 (9.16) | 38 (64.4) | < 0.001 |
ICU stays (d) | 0.00 (0.00; 0.00) | 0.00 (0.00; 10.0) | < 0.001 | 0.00 (0.00; 0.00) | 5.00 (0.00; 9.00) | < 0.001 |
Hospital stays (d) | 10.0 (7.00; 14.0) | 17.5 (8.75; 25.0) | < 0.001 | 9.00 (4.00; 15.0) | 23.0 (15.0; 30.0) | < 0.001 |
Mortality (%) | 0 (0.00) | 3 (3.75) | 0.007 | 1 (0.76) | 4 (6.78) | 0.033 |
qSOFA | 0.00 (0.00; 0.00) | 1.00 (0.00; 1.00) | < 0.001 | 0.00 (0.00; 1.00) | 1.00 (0.00; 1.00) | < 0.001 |
SIRS | 1.00 (0.00; 2.00) | 3.00 (2.00; 3.00) | < 0.001 | 1.00 (0.00; 2.00) | 3.00 (2.00; 3.00) | < 0.001 |
BISAP | 1.00 (0.00; 1.00) | 2.00 (2.00; 3.00) | < 0.001 | 1.00 (0.00; 2.00) | 2.00 (2.00; 3.00) | < 0.001 |
Table 2 Characteristics of non-acute respiratory distress syndrome and acute respiratory distress syndrome patients in derivation and validation cohorts
Characteristic | Derivation cohort | P value | Validation cohort | P value | ||
non-ARDS (n = 345) | ARDS (n = 62) | non-ARDS (n = 153) | ARDS (n = 37) | |||
Age (yr) | 49.0 (36.0; 64.0) | 42.0 (33.2; 59.5) | 0.062 | 40.0 (33.0; 57.0) | 48.0 (41.0; 57.0) | 0.082 |
Female (%) | 138 (40.0) | 20 (32.3) | 0.312 | 67 (43.8) | 10 (27.0) | 0.093 |
Weekend admission (%) | 73 (21.2) | 18 (29.0) | 0.228 | 39 (25.5) | 11 (29.7) | 0.751 |
Etiology (%) | 0.024 | 0.187 | ||||
Biliary | 122 (35.4) | 22 (35.5) | 56 (36.6) | 9 (24.3) | ||
Hypertriglyceridemia | 119 (34.5) | 30 (48.4) | 53 (34.6) | 12 (32.4) | ||
Alcoholic | 28 (8.12) | 6 (9.68) | 8 (5.23) | 5 (13.5) | ||
Others | 76 (22.0) | 4 (6.45) | 36 (23.5) | 11 (29.7) | ||
Peritoneal irritation (%) | 80 (23.2) | 25 (40.3) | 0.007 | 39 (25.5) | 20 (54.1) | 0.002 |
GCS < 15 (%) | 4 (1.16) | 3 (4.84) | 0.075 | 4 (2.61) | 6 (16.2) | 0.004 |
Tem (℃) | 36.6 (36.4; 37.0) | 37.5 (36.5; 38.2) | < 0.001 | 37.0 (36.8; 37.5) | 38.0 (37.8; 38.5) | < 0.001 |
SBP (mmHg) | 129 (119; 140) | 123 (110; 141) | 0.113 | 123 (116; 140) | 119 (106; 147) | 0.192 |
HR (bpm) | 82.0 (76.0; 96.0) | 120 (103; 134) | < 0.001 | 90.0 (80.0; 110) | 115 (100; 140) | < 0.001 |
RR (bpm) | 20.0 (18.0; 20.0) | 23.0 (20.0; 30.0) | < 0.001 | 20.0 (18.0; 22.0) | 24.0 (20.0; 29.0) | < 0.001 |
WBC (× 109/L) | 11.9 (8.76; 15.3) | 13.9 (9.91; 19.5) | 0.006 | 12.5 (9.07; 16.3) | 17.6 (13.6; 22.8) | < 0.001 |
HCT (%) | 40.8 (37.5; 44.8) | 45.2 (38.3; 48.7) | 0.002 | 41.3 (37.4; 45.2) | 43.9 (38.0; 49.4) | 0.094 |
PLT (× 109/L) | 218 (176; 275) | 207 (167; 274) | 0.26 | 228 (192; 278) | 208 (168; 261) | 0.112 |
K (mmol/L) | 3.90 (3.60; 4.30) | 3.90 (3.50; 4.20) | 0.441 | 3.90 (3.50; 4.20) | 3.90 (3.50; 4.40) | 0.429 |
Na (mmol/L) | 137 (134; 140) | 137 (132; 140) | 0.95 | 137 (133; 140) | 139 (132; 144) | 0.038 |
Ca (mmol/L) | 2.25 (2.12; 2.34) | 1.88 (1.65; 2.12) | < 0.001 | 2.16 (2.01; 2.29) | 1.96 (1.77; 2.22) | 0.002 |
Cr (μmol/L) | 67.0 (55.0; 81.0) | 86.5 (72.0; 134) | < 0.001 | 62.0 (53.0; 79.0) | 96.0 (65.0; 230) | < 0.001 |
BUN (mmol/L) | 5.03 (3.90; 6.44) | 7.28 (5.25; 10.3) | < 0.001 | 4.80 (3.37; 6.48) | 6.97 (5.37; 14.4) | < 0.001 |
Glu (mmol/L) | 8.10 (6.50; 13.1) | 11.0 (7.67; 16.1) | < 0.001 | 8.80 (6.90; 13.6) | 11.3 (8.10; 16.8) | 0.032 |
Local complication (%) | 115 (33.3) | 62 (100) | < 0.001 | 88 (57.5) | 33 (89.2) | 0.001 |
Ventilator (%) | 3 (0.87) | 4 (6.45) | 0.012 | 0 (0.00) | 23 (62.2) | < 0.001 |
ICU admission (%) | 16 (4.64) | 33 (53.2) | < 0.001 | 21 (13.7) | 29 (78.4) | < 0.001 |
ICU stays (d) | 0.00 (0.00; 0.00) | 2.50 (0.00; 11.8) | < 0.001 | 0.00 (0.00; 0.00) | 7.00 (1.00; 11.0) | < 0.001 |
Hospital stays (d) | 10.0 (7.00; 15.0) | 19.0 (11.0; 25.0) | < 0.001 | 10.0 (4.00; 19.0) | 23.0 (15.0; 30.0) | < 0.001 |
Mortality (%) | 1 (0.29) | 2 (3.23) | 0.062 | 1 (0.65) | 4 (10.8) | 0.005 |
Table 3 Multivariable logistic regression analysis for severe acute pancreatitis and acute respiratory distress syndrome prediction in derivation cohort
Variable | SAP | ARDS | ||||
β | OR (95% CI) | P value | β | OR (95% CI) | P value | |
Intercept | -6.42 | 0.00 (0.00-0.05) | < 0.001 | -5.46 | 0.00 (0.00-0.13) | 0.002 |
HR | 0.05 | 1.05 (1.04-1.07) | < 0.001 | 0.05 | 1.05 (1.03-1.07) | < 0.001 |
RR | 0.08 | 1.08 (1.00-1.17) | 0.047 | 0.10 | 1.10 (1.02-1.19) | 0.014 |
Ca | -1.30 | 0.26 (0.09-0.73) | 0.011 | -1.78 | 0.17 (0.06-0.48) | 0.001 |
BUN | 0.14 | 1.15 (1.09-1.23) | < 0.001 | 0.11 | 1.12 (1.05-1.19) | < 0.001 |
Table 4 Sensitivity, specificity, positive predictive value, negative predictive value for of the predictive models in combined cohort
SAP | ARDS | ||||||||||
PA | SE | SP | Youden index | PPV | NPV | PA | SE | SP | Youden index | PPV | NPV |
> 10% | 0.91 | 0.63 | 0.54 | 0.43 | 0.96 | > 5% | 0.94 | 0.48 | 0.42 | 0.26 | 0.98 |
> 20% | 0.82 | 0.83 | 0.65 | 0.59 | 0.94 | > 10% | 0.85 | 0.71 | 0.56 | 0.37 | 0.96 |
> 25% | 0.78 | 0.88 | 0.66 | 0.66 | 0.93 | > 18% | 0.78 | 0.85 | 0.63 | 0.51 | 0.95 |
> 40% | 0.71 | 0.93 | 0.64 | 0.75 | 0.91 | > 30% | 0.67 | 0.93 | 0.59 | 0.65 | 0.93 |
> 60% | 0.51 | 0.97 | 0.48 | 0.84 | 0.87 | > 50% | 0.46 | 0.96 | 0.43 | 0.71 | 0.90 |
> 80% | 0.32 | 0.99 | 0.30 | 0.88 | 0.83 | > 70% | 0.29 | 0.98 | 0.27 | 0.71 | 0.87 |
> 95% | 0.14 | 1.00 | 0.14 | 0.91 | 0.79 | > 85% | 0.12 | 1.00 | 0.12 | 0.86 | 0.85 |
- Citation: Li YL, Zhang DD, Xiong YY, Wang RF, Gao XM, Gong H, Zheng SC, Wu D. Development and external validation of models to predict acute respiratory distress syndrome related to severe acute pancreatitis. World J Gastroenterol 2022; 28(19): 2123-2136
- URL: https://www.wjgnet.com/1007-9327/full/v28/i19/2123.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i19.2123